MedTrace Logo

Quality of Life in Pancreas Transplantation

NCT03921593 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 110

Last updated 2021-09-29

No results posted yet for this study

Summary

Quality of Life for individuals with Insulin Dependent Diabetes Mellitus (IDDM) can be severely impaired by acute and chronic complications of the disease.

Solid organ pancreatic transplantation restores endocrine pancreatic function. However, it is also burdened by high perioperative morbidity and mortality.

Clinical benefits and risks of this intervention have been extensively clarified, but our knowledge about quality of life gain, often mentioned among the assets of transplantation, is still limited.

This study aims to quantify the impact of all forms of Solid Organ Pancreas Transplantation on quality of life (QOL).

Conditions

Interventions

PROCEDURE

Solid Organ Pancreas Transplantation with or without Kidney Transplantation

Deceased donor pancreas transplantation

Sponsors & Collaborators

  • University of Oxford

    lead OTHER

Principal Investigators

  • Peter J Friend, MA, MB, FRCS, MD · University of Oxford

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-11-04
Primary Completion
2021-12-31
Completion
2022-03-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03921593 on ClinicalTrials.gov